Targacept Inc.

Industry · 16 registered clinical trials.

Status	Trial	Phase	Started
Completed	Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis Gastroparesis	Phase 1 / Phase 2	2014-06-01
Completed	Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overacti Overactive Bladder	Phase 2	2013-05-01
Completed	Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cogniti Schizophrenia, Negative Symptoms, Cognitive Dysfunction	Phase 2	2011-12-01
Completed	Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder ( Attention Deficit Hyperactivity Disorder	Phase 2	2011-11-01
Completed	Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (A Alzheimer's Disease	Phase 2	2011-10-01
Completed	TC-6987 for the Treatment of Mild to Moderate Asthma Asthma	Phase 2	2011-02-01
Completed	Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus	Phase 2	2011-01-01
Completed	Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease Alzheimer's Disease	Phase 1	2010-09-01
Completed	Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) ADHD	Phase 2	2010-05-01
Completed	Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS Irritable Bowel Syndrome	Phase 2	2010-05-01
Completed	TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophreni Cognitive Dysfunction, Schizophrenia	Phase 2	2009-10-01
Terminated	TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension Refractory Hypertension	Phase 1 / Phase 2	2009-05-01
Completed	TC-5214 as add-on the Treatment of Major Depressive Disorder Major Depressive Disorder, Depression	Phase 2	2008-06-01
Completed	A Safety and Tolerability Single Ascending Dose Study in Healthy Volunteers Healthy	Phase 1	2007-01-01
Completed	Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder Major Depressive Disorder	Phase 2	2005-02-01
Completed	A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (A Age-Related Memory Disorders	Phase 2	2005-01-01